References

Unresolved reference

External reference

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

10.1016/s1473-3099(15)00485-5 · 2016 · External reference

HIV/hepatitis C coinfection natural history and disease progression

10.1097/coh.0b013e32834bd365 · 2011 · External reference

Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy

10.1093/cid/ciw219 · 2016 · External reference

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

10.1016/s0140-6736(14)60604-8 · 2014 · External reference

Unresolved reference

External reference

Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO

10.1016/s2468-1253(21)00311-3 · 2022 · External reference

Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel

10.1097/qad.0000000000002622 · 2020 · External reference

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019

10.1016/j.eclinm.2022.101810 · 2023 · External reference

Unresolved reference

External reference

Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial

10.1093/cid/ciaa1500 · 2021 · External reference

Decreasing prevalence and stagnating incidence of Hepatitis C-co-infection among a cohort of HIV-1-positive patients, with a majority of men who have sex with men, in Germany, 1996–2019

10.1111/jvh.13670 · 2022 · External reference

Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands

10.1097/qad.0000000000003159 · 2022 · External reference

Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study

10.1111/liv.15754 · 2024 · External reference

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

10.1093/ije/dyad154 · 2023 · External reference

Estimating predicted probabilities from logistic regression: different methods correspond to different target populations

10.1093/ije/dyu029 · 2014 · External reference

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies

10.1016/s2352-3018(23)00267-9 · 2024 · External reference

Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

10.1111/hiv.13229 · 2022 · External reference

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia

10.1016/j.jhep.2019.04.014 · 2019 · External reference

Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C. JAIDS

10.1097/qai.0000000000003646 · 2025 · External reference

DAA treatment for HCV reduce risk of hepatocellular carcinoma: a 10-years follow-up study based on Chinese patients with hepatitis C

2024 · External reference

Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada

10.1016/j.lana.2023.100658 · 2024 · External reference

Long Term Clinical Outcomes in Chronic Hepatitis C Patients Who Achieved SVR Following DAAs: A Decade Long Prospective Study

10.1111/jvh.70044 · 2025 · External reference

Hepatitis C treatment outcome among people in prison: The SToP-C study

10.1111/liv.16074 · 2024 · External reference

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands

10.1186/s41124-018-0040-9 · 2018 · External reference

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort

10.4414/smw.2021.20460 · 2021 · External reference

Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review

10.3390/ijerph19031749 · 2022 · External reference

Impact of COVID-19 on global HCV elimination efforts

10.1016/j.jhep.2020.07.042 · 2021 · External reference

Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men

10.1053/j.gastro.2009.02.006 · 2009 · External reference